This webinar will give you direct guidance on how GHG baselines, SBTi targets and feasibility assessments can be set and completed in a matter of months with the right support, including an overview of the new expectations and how suppliers can respond to them quickly.
In 2026, SBTi-aligned targets are becoming a minimum entry requirement for tier 1 pharma suppliers, both in new tenders and to retain existing business relationships. Large pharma companies are moving to reduce their Green House Gas (GHG) emissions, the majority of which are found in Scope 3 emissions.
Read more and sign up!
